The external domains of the HIV-1 envelope are a mutational cold spot

Nature Communications

Volumn 6, Issue , 2015, Pages

  Geller, Ron ^a   Domingo Calap, Pilar ^a,b   Cuevas, José M ^a   Rossolillo, Paola ^b   Negroni, Matteo ^b   Sanjuán, Rafael ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIUM; CATALYSIS; DNA; ENZYME ACTIVITY; FITNESS; GENOME; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; MUTATION; PATHOGEN; PROTEIN; RNA; SURVIVAL; VIRUS;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

VIRUS ENVELOPE PROTEIN;

CHEMISTRY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MUTATION RATE; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

HIV INFECTIONS; HIV-1; HUMANS; MUTATION RATE; PROTEIN STRUCTURE, TERTIARY; VIRAL ENVELOPE PROTEINS;

EID: 84944061856     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9571     Document Type: Article

References (60)

1. Kimura, M. On the evolutionary adjustment of spontaneous mutation rates. Genet. Res. 9, 23-34 (1967
2. Lynch, M. Evolution of the mutation rate. Trends Genet. 26, 345-352 (2010
3. Metzgar, D., & Wills, C. Evidence for the adaptive evolution of mutation rates. Cell 101, 581-584 (2000
4. Rando, O. J., & Verstrepen, K. J. Timescales of genetic and epigenetic inheritance. Cell 128, 655-668 (2007
5. Moxon, R., Bayliss, C., & Hood, D. Bacterial contingency loci: the role of simple sequence DNA repeats in bacterial adaptation. Annu. Rev. Genet. 40, 307-333 (2006
6. Martincorena, I., Seshasayee, A. S., & Luscombe, N. M. Evidence of nonrandom mutation rates suggests an evolutionary risk management strategy. Nature 485, 95-98 (2012
7. Teng, G., & Papavasiliou, F. N. Immunoglobulin somatic hypermutation. Annu. Rev. Genet. 41, 107-120 (2007
8. Liu, M., et al. Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage. Science 295, 2091-2094 (2002
9. Arambula, D., et al. Surface display of a massively variable lipoprotein by a Legionella diversity-generating retroelement. Proc. Natl Acad. Sci. USA 110, 8212-8217 (2013
10. Elde, N. C., et al. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 150, 831-841 (2012
11. Duffy, S., Shackelton, L. A., & Holmes, E. C. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9, 267-276 (2008
12. Sanjuán, R., Nebot, M. R., Chirico, N., Mansky, L. M., & Belshaw, R. Viral mutation rates. J. Virol. 84, 9733-9748 (2010
13. Domingo, E. Quasispecies: Concept and Implications for Virology (Springer, 2006
14. Holmesc, E C. The Evolution and Emergence of RNA Viruses (Oxford University Press, 2009
15. Julien, J. P., et al. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342, 1477-1483 (2013
16. Lyumkis, D., et al. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342, 1484-1490 (2013
17. Merk, A., & Subramaniam, S. HIV-1 envelope glycoprotein structure. Curr. Opin. Struct. Biol. 23, 268-276 (2013
18. Kwong, P. D., Mascola, J. R., & Nabel, G. J. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat. Rev. Immunol. 13, 693-701 (2013
19. Reitter, J. N., Means, R. E., & Desrosiers, R. C. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4, 679-684 (1998
20. Menéndez-Arias, L. Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses 1, 1137-1165 (2009
21. Boyer, P. L., Stenbak, C. R., Hoberman, D., Linial, M. L., & Hughes, S. H. In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. Virology 367, 253-264 (2007
22. Bebenek, K., Abbotts, J., Roberts, J. D., Wilson, S. H., & Kunkel, T. A. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J. Biol. Chem. 264, 16948-16956 (1989
23. Menéndez-Arias, L. in Human Immunodeficiency Virus Reverse Transcriptase: A Bench-To-Bedside Success (eds. Le Grice, S. F., & Götte, M.) 225-252 (Springer Science and Business Media, 2013
24. Chiu, Y. L., & Greene, W. C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317-353 (2008
25. Gartner, K., et al. Accuracy estimation of foamy virus genome copying. Retrovirology 6, 32 (2009
26. Holtz, C. M., & Mansky, L. M. Variation of HIV-1 mutation spectra among cell types. J. Virol. 87, 5296-5299 (2013
27. Gout, J. F., Thomas, W. K., Smith, Z., Okamoto, K., & Lynch, M. Large-scale detection of in vivo transcription errors. Proc. Natl Acad. Sci. USA 110, 18584-18589 (2013
28. O'Neil, P. K., et al. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J. Biol. Chem. 277, 38053-38061 (2002
29. Armitage, A. E., et al. Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences. J. Virol. 82, 8743-8761 (2008
30. Bishop, K. N., Holmes, R. K., Sheehy, A. M., & Malim, M. H. APOBECmediated editing of viral RNA. Science 305, 645 (2004
31. Harris, R. S., Petersen-Mahrt, S. K., & Neuberger, M. S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell. 10, 1247-1253 (2002
32. Pathak, V. K., & Temin, H. M. 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J. Virol. 66, 3093-3100 (1992
33. Galetto, R., et al. The structure of HIV-1 genomic RNA in the gp120 gene determines a recombination hot spot in vivo. J. Biol. Chem. 279, 36625-36632 (2004
34. Simon-Loriere, E., et al. Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog. 5, e1000418 (2009
35. Watts, J. M., et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460, 711-716 (2009
36. Giguegggre, T., Adkar-Purushothama, C. R., & Perreault, J. P. Comprehensive secondary structure elucidation of four genera of the family Pospiviroidae. PLoS ONE 9, e98655 (2014
37. Gago, S., Elena, S. F., Flores, R., & Sanjuán, R. Extremely high mutation rate of a hammerhead viroid. Science 323, 1308 (2009
38. Cuevas, J. M., González-Candelas, F., Moya, A., & Sanjuán, R. The effect of ribavirin on the mutation rate and spectrum of Hepatitis C virus in vivo. J. Virol. 83, 5760-5764 (2009
39. Ribeiro, R. M., et al. Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate. PLoS Pathog. 8, e1002881 (2012
40. Keele, B. F., et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad. Sci. USA 105, 7552-7557 (2008
41. Abrahams, M. R., et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J. Virol. 83, 3556-3567 (2009
42. Ho, Y. C., et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540-551 (2013
43. LeClerc, J. E., Li, B., Payne, W. L., & Cebula, T. A. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-1211 (1996
44. Pal, C., Macia, M. D., Oliver, A., Schachar, I., & Buckling, A. Coevolution with viruses drives the evolution of bacterial mutation rates. Nature 450, 1079-1081 (2007
45. Al Mamun, A. A., et al. Identity and function of a large gene network underlying mutagenic repair of DNA breaks. Science 338, 1344-1348 (2012
46. Rosenberg, S. M. Evolving responsively: adaptive mutation. Nat. Rev. Genet. 2, 504-515 (2001
47. Sanjuán, R. From molecular genetics to phylodynamics: evolutionary relevance of mutation rates across viruses. PLoS Pathog. 8, e1002685 (2012
48. Coffey, L. L., Beeharry, Y., Borderia, A. V., Blanc, H., & Vignuzzi, M. Arbovirus high fidelity variant loses fitness in mosquitoes and mice. Proc. Natl Acad. Sci. USA 108, 16038-16043 (2011
49. Dapp, M. J., Clouser, C. L., Patterson, S., & Mansky, L. M. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. J. Virol. 83, 11950-11958 (2009
50. Vignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E., & Andino, R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439, 344-348 (2006
51. Monajemi, M., et al. Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8 T cells. PLoS ONE 9, e93428 (2014
52. Sadler, H. A., Stenglein, M. D., Harris, R. S., & Mansky, L. M. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. J. Virol. 84, 7396-7404 (2010
53. Jern, P., Russell, R. A., Pathak, V. K., & Coffin, J. M. Likely role of APOBEC3G-mediated G-To-A mutations in HIV-1 evolution and drug resistance. PLoS Pathog. 5, e1000367 (2009
54. Sanjuán, R., & Border?á, A. V. Interplay between RNA structure and protein evolution in HIV-1. Mol. Biol. Evol. 28, 1333-1338 (2010
55. Hamoudi, M., Simon-Loriere, E., Gasser, R., & Negroni, M. Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality. Retrovirology 10, 114 (2013
56. Wang, W., et al. A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. Retrovirology 10, 14 (2013
57. Wei, X., et al. Antibody neutralization and escape by HIV-1. Nature 422, 307-312 (2003
58. Matamoros, T., Barrioluengo, V., Abia, D., & Menéndez-Arias, L. Major groove binding track residues of the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase enhance cDNA synthesis at high temperatures. Biochemistry 52, 9318-9328 (2013
59. Garc?á-Merino, I., et al. The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology 6, 27 (2009
60. Sandon?s, V., et al. A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs. Virology 391, 73-82 (2009